Previous studies have shown that increasing MBNL1 proteins or mRNA levels by a minimum 1.5-fold were sufficient to partially reverse aberrant splicing and ameliorate the phenotype of DM1 mice [120,121]. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.